Laurel Habel to Lovastatin
This is a "connection" page, showing publications Laurel Habel has written about Lovastatin.
Connection Strength
0.077
-
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf. 2008 Jan; 17(1):27-36.
Score: 0.077